Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

Apogee Therapeutics Directors Exercise Stock Options

Fairmount Funds Management LLC, Fairmount Healthcare Fund II L.P., Tomas Kiselak, and Peter Harwin filed a joint Form 4 on August 11, 2026, reporting stock option exercises in Apogee Therapeutics, Inc. (NASDAQ:APGE) dated August 7, 2026.

Aakashdeep | 11 August 2026

Interface Inc Chief Accounting Officer Sells 8,000 Shares

Robert Pridgen, Chief Accounting Officer of Interface Inc, filed a Form 4 on August 11, 2026, disclosing the sale of 8,000 shares of Interface Inc common stock on that same date.

Shwetambri Chauhan | 11 August 2026

Apogee Therapeutics Stockholders Approve AbbVie Merger

Apogee Therapeutics, Inc. filed a Form 8-K on August 11, 2026, disclosing the results of a special stockholder meeting held the same day, at which shareholders voted to adopt the merger agreement with a subsidiary of AbbVie Inc., and reporting the anticipated resignations of …

Shwetambri Chauhan | 11 August 2026

Federal Realty OP LP Issues $460M Exchangeable Senior Notes

Federal Realty Investment Trust and its operating partnership, Federal Realty OP LP, filed a Form 8-K on August 11, 2026, disclosing the issuance of $460,000,000 in aggregate principal amount of 3.500% Exchangeable Senior Notes due 2031.

Manish Choudhary | 11 August 2026

Sanara MedTech Enters Merger Agreement with MiMedx

Sanara MedTech Inc. filed an amended Form 8-K/A on August 11, 2026, correcting termination fee amounts reported in its original July 29, 2026 current report disclosing an Agreement and Plan of Merger with MiMedx Group, Inc.

Nitish Kishor | 11 August 2026

Boston Beer Enters $25M Stock Repurchase Plan

The Boston Beer Company, Inc. filed an 8-K on August 11, 2026, disclosing that it entered into a 10b5-1 plan on August 10, 2026, to repurchase up to $25 million of its Class A Common Stock between September 28, 2026, and December 25, 2026.

Nitish Kishor | 11 August 2026

Aquestive Therapeutics Reports Q2 2026 Financial Results

Aquestive Therapeutics, Inc. filed a Form 8-K with the U.S. Securities and Exchange Commission on August 11, 2026, reporting its financial results for the second quarter ended June 30, 2026, and disclosing an investor presentation furnished under Regulation FD.

Anjali Anand | 11 August 2026

AnaptysBio 2026 Annual Meeting Voting Results

AnaptysBio, Inc. filed an 8-K on August 11, 2026, reporting the voting outcomes from its 2026 Annual Meeting of Stockholders held that same day on four separate proposals.

Nitish Kishor | 11 August 2026

Burke & Herbert CFO Receives Change in Control Agreement

Burke & Herbert Financial Services Corp. filed a Form 8-K on August 11, 2026, disclosing that it entered into a change in control agreement with Executive Vice President and Chief Financial Officer Kirtan Parikh, effective July 6, 2026.

Shwetambri Chauhan | 11 August 2026

Super Micro Computer Reports Q4 and Full Fiscal Year 2026 Results

Super Micro Computer, Inc. filed a Form 8-K with the SEC on August 11, 2026, announcing unaudited financial results for the quarter and full fiscal year ended June 30, 2026, via an attached press release.

Aditi Sarkar | 11 August 2026
Support

Hi! How can we help you today?

Loading…